| GlaxoSmithKline AG - Arnuity Ellipta 46 mcg, Einzeldosiertes Pulver zur Inhalation |
| 65707 | | 03 | | Arnuity Ellipta 46 mcg | | Einzeldosiertes Pulver zur Inhalation | | R03BA09 | | Fluticasone Furoate | | 18.10.2018 | | |
|
| Composition |
| fluticasoni furoas 46 µg, lactosum monohydricum ad pulverem pro dosi, doses pro vase 30. |
| Packungsbestandteile |
| Einzeldosiertes Pulver zur Inhalation | | | | | | Active Agent | Dose |
|---|
| Fluticasoni Furoas | 46 µg |
| | | | Inactive agents |
|---|
| Lactose Monohydrate |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 30 | PR | PR | B | | Yes |
|
